Skip to main content

Vildagliptin anti-diabetic agent

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-62759

Catalog #
Availability
Size / Price
Qty
Loading...
NBP2-62759-100mg
NBP2-62759-20mg

Key Product Details

Applications

Immunoprecipitation

Product Summary for Vildagliptin anti-diabetic agent

Anti-diabetic agent
Purity: >98% (HPLC); NMR (conforms)
CAS No.: 274901-16-5
Molecular Formula: C17H25N3O2
Molecular Weight: 303.4
Source: Synthetic
Appearance: White powder
PubChem ID: 11077541

Product Specifications

Application Notes

White powder. May be dissolved in DMSO (45 mg/mL); or DMF (20 mg/mL); or ethanol (20 mg/mL).

Scientific Data Images for Vildagliptin anti-diabetic agent

Vildagliptin anti-diabetic agent [NBP2-62759] - Chemical structure of Vildagliptin, a Antidiabetic Agent. CAS #: 274901-16-5 . Molecular Formula: C17H25N3O2. Molecular Weight: 303.4 g/mol.

Formulation, Preparation, and Storage

Concentration

Please see the protocols for proper use of this product. If no protocol is available, contact technical services for assistance.

Shipping

The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.

Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: Vildagliptin anti-diabetic agent

Vildagliptin is a potent inhibitor of dipeptidyl peptidase IV (DPP IV), an enzyme that cleaves glucagon-like peptide 1 (GLP-1) (1). Delaying the degradation of GLP-1 extends the action of insulin and suppresses the release of glucagon which results in reduction in elevated blood glucose levels (hyperglycemia) (2). It is a clinically useful antidiabetic agent.

Additional Vildagliptin anti-diabetic agent Products

Product Documents for Vildagliptin anti-diabetic agent

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for Vildagliptin anti-diabetic agent

Signal Word: Warning GHS Classifcation: GHS07 Acute toxicity (oral, dermal, inhalation), category 4
Skin irritation, category 2
Eye irritation, category 2
Skin sensitisation, category 1
Specific Target Organ Toxicity - Single exposure, category 3 Hazard statement(s):
H302 H315 Causes skin irritation.
H319 Causes serious eye irritation.
H335 May cause respiratory irritation.

Precautionary statement(s): P301 + P312 + P330-P305 + P351 + P338

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Support products are guaranteed for 6 months from date of receipt.

Loading...
Loading...
Loading...
Loading...